The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study

Cesare Hassan, V De Francesco, A Zullo, N Della Valle, L Pietrini, Mf Minenna, S Winn, R Monno, V Stoppino, S Morini, C Panella, E. Ierardi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

73 Citazioni (Scopus)

Abstract

One-week triple therapy for Helicobacter pylori revealed, during these last few years, a decrease in the eradication rate, so that the prolongation of its duration has been proposed. A sequential scheme recently showed very satisfactory results. We performed a prospective randomised study with the aim of either evaluating whether the triple therapy prolongation may improve its effectiveness and comparing its outcome with that of sequential regimen.
Lingua originaleEnglish
pagine (da-a)322-326
Numero di pagine5
RivistaDIGESTIVE AND LIVER DISEASE
Volume36
Stato di pubblicazionePubblicato - 2004
Pubblicato esternamente

Keywords

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Amoxicillin
  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Antitrichomonal Agents
  • Benzimidazoles
  • Clarithromycin
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Dyspepsia
  • Female
  • Helicobacter Infections
  • Helicobacter pylori
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Omeprazole
  • Patient Compliance
  • Peptic Ulcer
  • Prospective Studies
  • Smoking
  • Tinidazole
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study'. Insieme formano una fingerprint unica.

Cita questo